Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Compare Effectiveness of Eplerenone vs Atenolol in Reversing the Remodelling Resistance Arteries in Subjects With HT

This study has been completed.
Information provided by:
Pfizer Identifier:
First received: September 2, 2005
Last updated: April 14, 2008
Last verified: May 2007
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: May 2006 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):